Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 13/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ATR | Q13535 | 2/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 3/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8090420 | 0.96 | PIK3CD (0.41) | PIK3CDPIK3CAPOLBATRJAK2 | |
| SCHEMBL8089738 | 0.96 | PIK3CD (0.41) | PIK3CDPIK3CAPOLBATRJAK2 | |
| SCHEMBL8096026 | 0.92 | POLB (0.40) | PIK3CDPIK3CAPOLBJAK2MTOR | |
| SCHEMBL8090994 | 0.90 | POLB (0.39) | PIK3CDPIK3CAPOLBATRJAK2 | |
| SCHEMBL8090278 | 0.89 | PIK3CD (0.45) | PIK3CDPIK3CAPOLBJAK2MTOR | |
| SCHEMBL8096233 | 0.88 | PIK3CD (0.40) | PIK3CDPIK3CAPOLBATR | |
| SCHEMBL8093619 | 0.88 | PIK3CD (0.41) | PIK3CDPIK3CAPOLBJAK2MTOR | |
| SCHEMBL8095771 | 0.88 | PIK3CD (0.43) | PIK3CDPIK3CAPOLBJAK2MTOR | |
| SCHEMBL8098248 | 0.88 | PIK3CD (0.39) | PIK3CDPIK3CAPOLB | |
| SCHEMBL8089962 | 0.87 | PIK3CD (0.42) | PIK3CDPIK3CAPOLBJAK2MTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |